IMI Nyoman Bayu Mahendra

I Nyoman Bayu Mahendra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I Nyoman Bayu Mahendra has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analisis Hukum Batasan Tanggung Jawab dan Perlindungan Pasien dalam Penggunaan Kecerdasan Buatan Untuk Diagnosis Medis di Fasilitas Pelayanan Kesehatan

    by I Dewa Kadek Buda Prayuda, I Nyoman Bayu Mahendra

    Penelitian ini mengkaji kekosongan hukum terkait penentuan pihak yang bertanggung jawab ketika terjadi kesalahan diagnosis oleh kecerdasan buatan dalam layanan kesehatan di Indonesia. Dengan metode penelitian hukum normatif-yuridis melalui pendekatan perundang-undangan, konseptual, dan perbandingan, penelitian menelaah regulasi yang berlaku, termasuk UU Kesehatan 2023, UU Perlindungan Konsumen, dan KUHPerdata. Temuan menunjukkan bahwa kerangka hukum Indonesia belum memadai untuk mengatur tanggung jawab atas kesalahan diagnosis oleh sistem AI. Penelitian ini mengusulkan penerapan prinsip tanggung jawab mutlak bagi pengembang atau produsen perangkat lunak medis sebagai solusi yang paling adil, disertai pembagian tanggung jawab yang jelas serta mekanisme transparansi dan audit algoritma yang ketat.


  • Open Access

    CHARACTERISTICS OF PLACENTA PREVIA AT PROF. DR. I.G.N.G. NGOERAH CENTRAL GENERAL HOSPITAL IN 2022-2023

    by Yovilia Tio Yunus, I Gede Ngurah Harry Wijaya Surya, I Nyoman Bayu Mahendra, I Nyoman Gede Budiana

    Placenta previa can cause the mother to experience bleeding with all its complications so it can lead to maternal death if not handled optimally. Hence, serious attention needs to be given to this matter. This study aims to determine the characteristics of placenta previa at Prof. Dr. I.G.N.G. Ngoerah Hospital in 2022-2023 based on maternal age, number of parity, pregnancy interval, cesarean section surgery history, curettage history, placenta accreta history, endometriosis history, and uterine myoma history. This study uses a descriptive method of cross sectional and uses a total sampling technique. The subjects of the study were all pregnant women with placenta previa at Prof. Dr. I.G.N.G. Ngoerah Hospital Denpasar. This research data is secondary data obtained from medical records at Prof. Dr. I.G.N.G. Ngoerah Hospital Denpasar from January 1, 2022 to December 31, 2023. The collected data is processed, and presented in the form of tables and narratives. In this study, the number of samples that met the inclusion and exclusion criteria was 38 samples. The highest percentage of cases was found in the age of 21-34 years (65.8%). Most of them belonged to the multipara group (50.0%), had a pregnancy gap of > 2 years (60.5%), and had a history of cesarean section surgery (73.7%). In addition, more cases had no history of curettage (73.7%), no history of placenta accreta (65.8%), no history of endometriosis (97.4%), and no history of uterine myoma (92.1%). Based on the results of the study, it can be concluded that the characteristics of placenta previa at Prof. Dr. I.G.N.G. Ngoerah Hospital in 2022-2023 are at most 21-34 years old, multipara, have a pregnancy interval of > 2 years, have a history of cesarean section surgery, no history of curettage, no history of placenta accreta, no history of endometriosis, and no history of uterine myoma. Keywords : Placenta previa, pregnant women, Prof. Dr. I.G.N.G. Ngoerah Denpasar Hospital

  • Open Access

    HPV18 E6/E7 Mutation and Their Association with The Expression Level of Tumor Suppressor Proteins p53 and pRb among Indonesian Women with Cervical Cancer

    by I Nyoman Bayu Mahendra, Pande Kadek Aditya Prayudi, Ida Bagus Nyoman Putra Dwija

    BACKGROUND: The E6/E7 mutation contributes to the intra-typic variant of HPV18 which may differ in their oncogenic potential. E6 and E7 target the tumour suppressor protein p53 and pRb, respectively, and their degradation play a crucial role in cervical carcinogenesis. However, the prevalence of HPV18 E6/E7 variants among Indonesian women with cervical cancer has not been elucidated. Therefore, this study was conducted to characterize the HPV18 variants among Indonesian women with cervical cancer and their association with tumor suppressor protein p53 and pRb.METHODS: A hundred Indonesian women with pathologically proven cervical cancer were consecutively recruited into the study. Polymerase chain reaction (PCR) was performed to detect HPV18 DNA E6 and E7 oncogenes using specific primers and the variants was determined through nucleotide sequencing. Expressions of p53 and pRb were analyzed through immunohistochemistry by using specific antibodies targeting p53 and pRB.RESULTS: The rate of HPV18 positivity was 24%. The rate of E6 and E7 mutation was 45.4% and 59.1%, respectively. Those with E6 mutation had significantly higher expression of p53 and pRb as compared to those with wildtype E6 (p<0.05). Subjects with E7 mutation only had higher expression of pRb (p<0.05). Phylogenetic analysis revealed that 54.5% subjects had genetic sequences closely related to Asian lineages, particularly A1, A4, and A5 sublineage. Interestingly, 3 subjects had genetic sequences closely related to MK813921, a newly identified sequences. However, 45.5% subjects had distinct genetic sequences that did not related to the reference sequence used in this study.CONCLUSION: E6 and E7 mutation was common among Indonesian women with HPV18 cervical cancer and associated with the level of tissue p53 and pRb expression.KEYWORDS: HPV18 E6/E7, mutation, epidemiology, Indonesian women


  • Open Access

    Polimorfisme gen COL5A1 rs3827852 sebagai faktor risiko terjadinya prolaps organ panggul pada perempuan Bali

    by Putu Gede Agus Surya Mahardika, I Gede Mega Putra, Kadek Fajar Marta, I Nyoman Hariyasa Sanjaya, I Nyoman Bayu Mahendra, Evert Solomon Pangkahila

    Introduction: Pelvic organ prolapse (POP) is a common condition affecting women, particularly the elderly, significantly impacting quality of life despite rarely causing severe morbidity. Previous studies have shown that risk factors such as age, parity, physical labor, and genetic factors, particularly COL5A1 gene polymorphism, play a role in POP development through alterations in pelvic floor collagen structure. This study aims to establish the association of COL5A1 gene polymorphism with the risk of POP in Balinese women. Method: This observational case-control study evaluates the relationship between COL5A1 rs3827852 polymorphism and POP in Balinese women aged 30-70 years. Cases involved POP patients, while controls included non-POP gynecological patients, with matching for parity, occupation, BMI, and menopause status. Venous blood samples were analyzed for genetic polymorphism, and data were processed using SPSS with Chi-Square tests and multivariate analysis to assess the relationship between independent variables and POP. Result: A total of 33 POP patients were matched with 33 non-POP controls. The mean age of participants was 58.44 ± 6.877 years. After controlling for confounding variables like parity, BMI, occupation, and menopause status through multivariate analysis, a significant association was found between COL5A1 rs3827852 polymorphism and POP risk. The Binary Logistic Regression test showed a p-value of 0.026 with an adjusted OR of 3.242 (95% CI: 1.148 – 9.154), indicating that individuals with this polymorphism had a 3.242-fold increased risk of POP compared to those with the wild-type genotype. Conclusion: COL5A1 rs3827852 gene polymorphism is a risk factor for pelvic organ prolapse in Balinese women. Screening for this polymorphism in high-risk Balinese women may help in preventing POP. Pendahuluan: Prolaps organ panggul (POP) adalah kondisi umum yang memengaruhi perempuan, terutama pada usia lanjut, dan berdampak signifikan terhadap kualitas hidup meskipun jarang menyebabkan morbiditas berat. Penelitian sebelumnya menunjukkan bahwa faktor risiko seperti usia, paritas, pekerjaan fisik, serta faktor genetik, khususnya polimorfisme gen COL5A1, berperan dalam perkembangan POP melalui perubahan struktur kolagen dasar panggul. Tujuan penelitian ini adalah untuk membuktikan polimorfisme gen COL5A1 sebagai faktor risiko terjadinya POP pada perempuan Bali. Metode: Penelitian ini merupakan studi observasional kasus-kontrol berpasangan yang mengevaluasi hubungan antara polimorfisme gen COL5A1 rs3827852 dengan kejadian prolaps organ panggul (POP) pada perempuan Bali usia 30-70 tahun. Kasus adalah pasien POP, sementara kontrol adalah pasien ginekologi yang tidak memiliki POP. Matching dilakukan berdasarkan paritas, pekerjaan, indeks massa tubuh (IMT), dan status menopause. Sampel darah vena diambil untuk analisis polimorfisme gen. Data dianalisis menggunakan SPSS dengan uji Chi-Square dan analisis multivariat untuk melihat hubungan antara variabel bebas dan kejadian POP. Hasil: Penelitian ini melibatkan 33 pasien POP sebagai kelompok kasus dan 33 pasien non-POP sebagai kelompok kontrol. Rata-rata usia sampel adalah 58,44 ± 6,877 tahun. Setelah mengontrol variabel perancu seperti paritas, IMT, pekerjaan, dan status menopause melalui analisis multivariat, ditemukan bahwa polimorfisme gen COL5A1 rs3827852 memiliki hubungan signifikan dengan risiko POP. Hasil uji Binary Logistic Regression menunjukkan nilai p = 0,026 dengan adjusted RO 3,242 (IK95% 1,148 – 9,154), yang mengindikasikan bahwa sampel dengan polimorfisme ini memiliki risiko 3,242 kali lebih besar mengalami POP dibandingkan sampel tanpa polimorfisme. Simpulan: Polimorfisme gen COL5A1 rs3827852 merupakan faktor risiko terjadinya prolaps organ panggul (POP) pada perempuan Bali. Peneliti menyarankan penapisan polimorfisme ini pada perempuan Bali dengan risiko tinggi untuk mencegah POP.

  • Open Access

    Current Management of CINV

    by I Nyoman Bayu Mahendra, William Alexander Setiawan

    Chemotherapy-induced nausea and vomiting (CINV) prevention is important to reduce overall morbidity and financial burden in patients receiving chemotherapy. Severe symptoms reduce the patient's quality of life and can interfere with further treatment. The five major forms of CINV (ie, acute, delayed, predicted, breakthrough, and refractory) often include 5-HT3 receptor antagonists, NK1 receptor antagonists, and various treatments that often include corticosteroids. Despite significant research and development efforts on antiemetics, treatment of CINV remains a major challenge, waiting for many needs to be adequately addressed, including those that are vulnerable to CINV despite adequately treated. This review hope to raise awareness and discuss current current CINV management.


  • Open Access

    Association between mutant E6 and E7 Human Papilloma Virus Type 16 oncogenes with cyclin D1 expression in cervical cancer: Observational study in Bali

    by I Nyoman Bayu Mahendra, I Nyoman Gede Budiana, I Gede Mega Putra, Anom Suardika, Anak Agung Gede Putra Wiradnyana, Alisza Novrita Sari

    Background: Incidence of cervical cancer is higher in low- and middle-income countries, including Indonesia. In Asia, Indonesia ranks second both in mortality and incidence of cervical cancer. Infection by Human Papilloma Virus (HPV) type 16 is a known risk factor, especially with mutations of the E6 or E7 oncogene that lead to chronic infection and malignancy. Increase in cyclin D1 expression is found on cervical cancer cells, including those resistant to chemotherapy. The role of cyclic D1 in increasing cellular proliferation and decreasing apoptosis leads to cervical cancer. Methods: This study was a cross-sectional observational study carried out between August 2020 until August 2021 at Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar, Bali, Indonesia. Samples were collected by consecutive sampling of eligible patients. Polyclinic patients newly diagnosed with cervical cancer and who gave informed consent were further examined. We determined their oncogene E6 and E7 HPV type 16 mutation patterns and their association with cyclin D1 expression using contingency coefficient correlation test. Other outcomes including age distribution, parturition history, BMI, pathological type, clinical stage, and E6/E7 mutation characteristics was also recorded. Results: We included 31 eligible subjects with cervical cancer and HPV type 16-positive, divided into mutant E6/E7 (n=12/31; 38.7%) and wild type (n=19/31;61.3%). Primary outcome of association between mutant oncogene and cyclin D1 expression was weak (c=0.283; p-value=0.1). Secondary outcome showed majority of age on 50 years old or over; normal or overweight BMI; squamous cell carcinoma was the most commonly found (n=28/31; 90%); and clinical stage II (n=18/31; 38%) in both groups. Conclusions: This study concluded that there is no association between mutation in the E6/E7 HPV type 16 oncogenes with cyclin D1 expression in patients with cervical cancer.

  • Open Access

    Whole-Genome Comparison of Representatives of All Variants of SARS-CoV-2, Including Subvariant BA.2 and the GKA Clade

    by Ida B. K. Suardana, Bayu K. Mahardika, Made Pharmawati, Putu H. Sudipa, Tri K. Sari, Nyoman B. Mahendra, Gusti N. Mahardika

    Since its discovery at the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into many variants, including the subvariant BA.2 and the GKA clade. Genomic clarification is needed for better management of the current pandemic as well as the possible reemergence of novel variants. The sequence of the reference genome Wuhan-Hu-1 and approximately 20 representatives of each variant were downloaded from GenBank and GISAID. Two representatives with no track of in-definitive nucleotides were selected. The sequences were aligned using muscle. The location of insertion/deletion (indel) in the genome was mapped following the open reading frame (ORF) of Wuhan-Hu-1. The phylogeny of the spike protein coding region was constructed using the maximum likelihood method. Amino acid substitutions in all ORFs were analyzed separately. There are two indel sites in ORF1AB, eight in spike, and one each in ORF3A, matrix (MA), nucleoprotein (NP), and the 3′-untranslated regions (3′UTR). Some indel sites and residues/substitutions are not unique, and some are variant-specific. The phylogeny shows that Omicron, Deltacron, and BA2 are clustered together and separated from other variants with 100% bootstrap support. In conclusion, whole-genome comparison of representatives of all variants revealed indel patterns that are specific to SARS-CoV-2 variants or subvariants. Polymorphic amino acid comparison across all coding regions also showed amino acid residues shared by specific groups of variants. Finally, the higher transmissibility of BA.2 might be due at least in part to the 48 nucleotide deletions in the 3′UTR, while the seem-to-be extinction of GKA clade is due to the lack of genetic advantages as a consequence of amino acid substitutions in various genes.


  • Open Access

    E6/E7 Oncogenes Mutation of Human Papillomavirus Type 16 Associated with P16 Protein Expression in Cervical Cancer

    by I Nyoman Bayu Mahendra, I Nyoman Gede Budiana, I Gede Mega Putra, Ryan Saktika Mulyana, I Gde Sastra Winata, Budi Setiawan Harjoto

    The genetic composition of the E6 and E7 oncogenes is very susceptible to mutation. Mutations occur due to interactions between the viral genome and the host. Changes in one nucleotide oncogenes E6 and E7 can affect the function of these oncogenes so that they can trigger the persistence of Human Papilloma Virus (HPV) infection and cervical cancer progression in several intratypic variants of HPV type 16 and alteration p16 expression in cervical cancer cases. This study was conducted on cervical cancer women first diagnosed from May 2021 to November 2021 who had not received surgery, chemotherapy, or radiation therapy. Willing to participate in the study after signing the informed consent. Cervical tissue samples with a positive test result for HPV 16 were then grouped based on the mutation sequencing of E6 and E7 into a wild-type group and a mutant group. Furthermore, the immunohistochemical examination was carried out to assess the expression of p16 protein in paraffin blocks. The results of this study showed that there was no association between mutations in the E6 and E7 oncogenes of HPV Type 16 with p16 expression (c= 0.048 and p value 0.78). The expression of p16 was stronger in the mutant group with the median percentage of cells from p16 immunohistochemistry staining which was 60.5% (range 3-73%) in the mutant group and 53% (range 2-65%) in the wild type of group. However, the correlation coefficient interval between HPV type 16 and E6 oncogene mutations with p16 protein expression is very weak.


  • Open Access

    The Clinical Use of Genomic Profiling for Prognosis Prediction in High Grade Serous Ovarian Cancer

    by I Nyoman Bayu Mahendra, Fransiskus Rendy, Pande Prayudi

    The majority of ovarian cancer cases are high-grade serous ovarian cancers (HGSOC). HGOSC harbors several genomic alterations that play crucial roles in carcinogenesis. Studies on the molecular characterization of HGSOC have suggested that HGSOC is a heterogenous disease, rather than a singular disease entity. Genomic profiling using gene expressions, methylation patterns, and non-coding RNA expression patterns have all been used as the basis for the molecular categorization of HGSOC. Understanding these classifications in relationship to the prognosis, such as overall survival, progression-free survival, and response to chemotherapy, is crucial in the age of precision medicine in order to direct specialized or targeted treatment and improve the prognosis. Research in the future will concentrate on creating therapies targeted at certain molecular subtypes.


  • Open Access

    Association Between E6 and E7 Human Papilloma Virus Type 16 Oncogen Mutations and P21 Protein Expression in Cervical Cancer

    by I Nyoman Bayu Mahendra, I Nyoman Gede Budiana, Made Suyasa Jaya, I Gede Mega Putra, I Nyoman Hariyasa Sanjaya, Musa Taufiq

    Cervical cancer is a disease characterized by the growth of abnormal cells in the cervical tissue. Cervical cancer is mostly caused by Human Papillomavirus (HPV) types 16 and 18. The role of genetic factors in the development of cervical malignancy is mediated by the presence of a mutation in the HPV 16 oncogene, especially oncogenes E6 and E7. Oncogenic proteins E6 and E7 in HPV initiate dysregulation of cellular proliferation and apoptotic mechanisms by targeting tumor suppressor proteins, such as the p21 protein. The purpose of this study was to assess the association between mutations in the E6 and E7 oncogenes of HPV-HR Type 16 and the pattern of p21 protein expression. This cross-sectional study was conducted at the Obstetrics and Gynecology Polyclinic of Prof. Dr. I.G.N.G. Ngoerah Hospital, from September 2020 to September 2021. The material taken was cervical cancer tissue from cervical cancer patients and then put into a preservative solution and then put in a cooler. DNA isolation was performed, and PCR was performed to determine positive and negative HPV. The amplification of the E6 and E7 genes was carried out before the sequencing and analysis of the E6 and E7 gene mutations was carried out. Then, immunohistochemical staining of p21 was carried out, followed by data analysis using SPSS for windows version 22.0. There were no significant differences in characteristics between the two groups. There was no association between mutations in the E6 and E7 HPV Type 16 oncogenes with p21 protein expression in cervical cancer cases (p-value 0.22).